Author

Jordan Carter

Cornell University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Avery AugustiD· 2 shared Hector C. AguilariD· 2 shared Julie SahleriD· 2 shared Shahrzad EzzatpouriD· 2 shared Adolfo García‐SastreiD· 1 shared Anastasija ČupićiD· 1 shared Annette ChoiiD· 1 shared Beatriz M. A. FontouraiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Avery AugustORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell-free expression of Nipah virus transmembrane proteins for proteoliposome vaccine design

Vivian T. Hu, Shahrzad Ezzatpour, Ekaterina Selivanovitch, Julie Sahler, Sreetama Pal, Jordan Carter, Quoc Vinh Pham, Richard Ayomide Adeleke, Avery August, Hector C. Aguilar, Susan Daniel, Neha P. Kamat

This paper develops a cell-free method to produce Nipah virus membrane proteins in liposomes for vaccine design, showing improved protein incorporation and enhanced immune responses in mice.

ACS Nano · Jun 3, 2025Peer-reviewedSynthetic Biology

Deletion of a KSF Motif Attenuates NSP1 Host Cell Translation Shutoff and Impairs SARS-CoV-2 Virulence

Chengjin Ye, Shahrzad Ezzatpour, Brian Imbiakha, Nathaniel D. Jackson, Tolga Çağatay, Anastasija Čupić, Lisa Miorin, Annette Choi, David W. Buchholz, Jordan Carter, Julie Sahler, Ximena A. Olarte‐Castillo, Mason C. Jager, Gary R. Whittaker, Avery August, , Hector C. Aguilar

This study shows that a deletion in the NSP1 protein of SARS-CoV-2 variants reduces virulence by impairing host translation shutoff, suggesting NSP1 as a target for antiviral strategies.

bioRxiv · Apr 16, 2025 · PreprintMicrobiology